The efficacy of Covid-19 vaccines can also vary in patients with distinct contexts of malignant disease (tumour type, disease extent, intrinsic or therapy-induced immune suppression). According to doctors, benefits of vaccination seem to outweigh the risks.
“The efficacy and duration of immunity in patients with cancer are still unknown and unexplored. Given the often-immune compromised status and the frailty of cancer patients, it is suggested to monitor in the context of registries and dedicated clinical trials. Close surveillance and monitoring of patients with cancer is required after Covid-19 vaccination to assess the potential adverse events and measure clinical outcomes like infection, severity and mortality from Covid-19, complications from cancer etc.,” Ajay Chanakya Vallabhaneni, Consultant Surgical Oncologist and Robotic Surgeon, KIMS Hospitals, told IANS.